Therapeutic Asset Ratings
482 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Botensilimab
Colorectal Cancer
National Cancer Institute (NCI)
P3
B
(63)
LENVATINIB
Colorectal Cancer
Seoul National University Bundang Hospital
P3
B
(63)
Nivolumab
Colorectal Cancer
Fred Hutchinson Cancer Center
P3
B
(63)
Cediranib
Colorectal Cancer
University Health Network, Toronto
P4
B
(62)
Dc-Cik
Colorectal Cancer
ShiCang Yu
P4
B
(62)
LIDOCAINE
Colorectal Cancer
Fudan University
P4
B
(62)
Catequentinib
Colorectal Cancer
Shanghai Changzheng Hospital
P3
B
(62)
Raltitrexed
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
P3
B
(62)
S-1
Colorectal Cancer
Tao Zhang
P3
B
(62)
Tucidinostat
Colorectal Cancer
Shanghai Changzheng Hospital
P3
B
(62)
rc48-adc
Colorectal Cancer
Anbogen Therapeutics, Inc.
P4
B
(61)
Serplulimab
Colorectal Cancer
Jiangsu Cancer Institute & Hospital
P4
B
(61)
Pyrotinib
Colorectal Cancer
Anbogen Therapeutics, Inc.
P3
B
(61)
TIPIRACIL
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
P3
B
(61)
Trifluridine
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
P3
B
(61)
Durvalumab
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest
P2
B
(61)
Bxcl501
Colorectal Cancer
Fudan University
P4
B
(60)
NEPENTHE
Colorectal Cancer
Local Health Unit Barcelos/Esposende, Public Health Unit
P4
B
(60)
Balstilimab
Colorectal Cancer
National Cancer Institute (NCI)
P3
B
(60)
Favezelimab
Colorectal Cancer
Merck Sharp & Dohme LLC
P3
B
(60)
FILGRASTIM
Colorectal Cancer
Roswell Park Cancer Institute
P3
B
(60)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.
P3
B
(60)
Letrozole
Colorectal Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P3
B
(60)
MITOMYCIN C
Colorectal Cancer
City of Hope Medical Center
P3
B
(60)
Epirubicin
Colorectal Cancer
National Cancer Center Hospital East
P2
B
(60)
Showing 26 to 50 of 482 assets
Previous
Page 2 of 20
Next